HOME >> BIOLOGY >> NEWS
Salk scientist Ursula Bellugi elected to National Academy of Sciences

LA JOLLA - Salk Institute professor Ursula Bellugi, who pioneered the study of the biological foundation of language, has been elected a member of the National Academy of Sciences. The Academy made the announcement today during its 144th annual meeting in Washington, DC. Election to the Academy recognizes distinguished and continuing achievements in original research, and is considered one of the highest honors accorded a U.S. scientist.

Dr. Bellugi, director of the Laboratory of Cognitive Neuroscience at the Salk Institute for Biological Studies, is regarded as the founder of the neurobiology of American Sign Language, since her research revealed that there are primary linguistic systems, passed down from one generation of deaf people to the next, which have been forged into a complexly structured language with complex grammatical properties not derived from spoken languages.

Before, it had been assumed that the organizational properties of language are connected with the sounds of speech. Her work has led to the finding that the left hemisphere of the human brain has an innate predisposition for language, even for a language in which spatial and visual processing plays a central role. This predisposition of certain brain systems to process language, whether spoken or signed, is a striking demonstration of neuronal plasticity.

During her whole career, Bellugi has been seeking new avenues for understanding the ties between molecular genetics, the brain and cognition. So she reached out across disciplines and assembled a team of experts under the umbrella of a Program Project from the National Institutes of Child Health and Human Development, one of the first of its kind, to help her trace the influence of individual genes on the development and function of the brain. Led by Bellugi, the researchers are looking to Williams syndrome to provide clues to some of the mysteries of the genetic basis of behavior. This puzzling genetically based disorder
'"/>

Contact: Gina Kirchweger
Kirchweger@salk.edu
858-453-4100 x1340
Salk Institute
1-May-2007


Page: 1 2

Related biology news :

1. Doernbecher Childrens Hospital scientist earns coveted Javits award
2. UK scientists working to help cut ID theft
3. Smithsonian scientists show differing patterns of rainforest biodiversity
4. Weizmann Institute scientists discover a control mechanism for metastasis
5. Cornell scientists link E. coli bacteria to Crohns disease
6. UCLA scientists produce functioning neurons from human embryonic stem cells
7. ASBMB taps 8 scientists and 1 politician for top awards
8. UF, French scientists seek test to detect gene doping in athletes
9. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
10. Universes stringy birth revealed by young Czech scientist in EURYI winning project
11. Forsyth scientists gain new understanding of adult stem cell regulation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, ... need a comparability study, but what is the most effective way to complete ...
(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, ... glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its ... are charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... 01, 2020 , ... Slone Partners , a nationwide ... placement of Julianne Averill , CPA, as Chief Financial Officer at ... implementing key business strategies to accelerate Alveo’s growth as the company advances its ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... available for free its new white paper – Simulated Transport Methodologies. Regulatory ... today’s biologics licensing application (BLA). In response, Modality Solutions shares an explanation ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
Breaking Biology Technology:
Cached News: